Dr. Reddy's Laboratories Ltd.

Dr. Reddy's Laboratories Ltd. We are a global pharmaceutical company committed to providing affordable & innovative medicines. Dr. Reddy’s Laboratories Ltd.

(BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY) is a global pharmaceutical company headquartered in Hyderabad, India. Established in 1984, we are committed to providing access to affordable and innovative medicines. Driven by our purpose of ‘Good Health Can’t Wait’, we offer a portfolio of products and services including APIs, generics, branded generics, biosimilars and OTC. Our major the

rapeutic areas of focus are gastrointestinal, cardiovascular, diabetology, oncology, pain management and dermatology. Our major markets include – USA, India, Russia & CIS countries, China, Brazil and Europe. As a company with a history of deep science that has led to several industry firsts, we continue to plan ahead and invest in businesses of the future. As an early adopter of sustainability and ESG actions, we released our first
Sustainability Report in 2004. Our current ESG goals aim to set the bar high in environmental stewardship; access and affordability for patients; diversity; and governance. For more information, log on to: www.drreddys.com. Dr. Reddy’s does not collect nor does it require you to share any personal data or personal information, towards your access to or participation in the Facebook event organised by it. You are advised to not disclose any personally identifiable or confidential or non-public information on social media; you are personally responsible for any data that you may decide to share or post on any social media including on this page and Dr. Reddy’s owes no duty or obligation or liability to you or to any other person for the same. All participants on this Facebook event are required to behave with courtesy to others and to not post any offensive/objectionable messages or to intrude into any other person’s rights of privacy.

We have been recognised for the third consecutive year in the 'Leadership' category of the Indian Corporate Governance S...
07/04/2026

We have been recognised for the third consecutive year in the 'Leadership' category of the Indian Corporate Governance Scorecard 2025, a joint initiative of Institutional Investor Advisory Services (IiAS), the International Finance Corporation (IFC), and the Bombay Stock Exchange (BSE).

The recognition follows an independent assessment of governance practices under the Indian Corporate Governance Scorecard framework and reflects our continued focus on transparency, accountability, and strengthening governance practices.

07/04/2026

Science drives everything we do, in how we understand the unmet needs of patients and work towards addressing them. It shapes our focus on access and affordability.

On World Health Day, we reaffirm this commitment, and the role of collective action in making it possible.

World Health Organization (WHO)

Our design team was awarded the "Best In-house Design Studio of the year" at the Economic Times Brand Equity Design & Cr...
02/04/2026

Our design team was awarded the "Best In-house Design Studio of the year" at the Economic Times Brand Equity Design & Creativity Awards.

Design thinking and the value of human centric design has always been something that our leaders have passionately evangelized in the organization. The team Studio 5B was setup 10 years ago by G. V. Prasad. Over the years the studio has worked across the value chain, designing experiences for employees, partners and patients. Ramana Motupalli

The award only encourages us to ensure that we keep the human at the centre of everything we do.

We have been featured among India’s top five most sustainable companies at the 5th edition of BW Businessworld’s India’s...
26/03/2026

We have been featured among India’s top five most sustainable companies at the 5th edition of BW Businessworld’s India’s Most Sustainable Companies Awards 2024–25. We ranked 4th overall and 1st in the healthcare and pharmaceutical category.

This award followed a rigorous evaluation of 200 companies and a second level assessment by an independent sector review. It strengthens our commitment to keep raising the bar on sustainability, to continue making a meaningful impact in the healthcare ecosystem and the communities we serve. BW Businessworld

G. V. Prasad, Co-Chairman and MD, reflecting on the moments that defined our journey, anchored by people and shaped by o...
25/03/2026

G. V. Prasad, Co-Chairman and MD, reflecting on the moments that defined our journey, anchored by people and shaped by our commitment to deep science, quality, and purpose, in conversation with Dandekar on Corner Office Conversation.

Source: The Economic Times | The Morning Brief podcast.

Our Chairman, Satish Reddy, joined the Hon’ble Chief Minister of Andhra Pradesh, N. Chandrababu Naidu, at the South Asia...
24/03/2026

Our Chairman, Satish Reddy, joined the Hon’ble Chief Minister of Andhra Pradesh, N. Chandrababu Naidu, at the South Asia Learning Summit at the Indian School of Business as he shared his perspectives on building a future‑ready state.



Read the article here: https://tinyurl.com/44yy3ztb

Chief Minister Chandrababu Naidu highlights Andhra Pradesh's rapid transformation and commitment to technology-driven progress and welfare.

With the launch of Obeda®, India’s first DCGI-approved semaglutide injection for Type 2 Diabetes, we are excited to supp...
21/03/2026

With the launch of Obeda®, India’s first DCGI-approved semaglutide injection for Type 2 Diabetes, we are excited to support diabetes care in India with high-quality, accessible and affordable treatment.

In a head-to-head Phase-III clinical study with 312 participants, Dr. Reddy’s Obeda® has shown non-inferior efficacy and similar safety to the innovator drug.

India’s rising rates of diabetes and obesity emphasize the growing need for reliable metabolic therapies. Our focus remains on informed use, patient support, and widening access. As with all prescription medicines, this treatment should be used under the guidance of a doctor.

We had the 4th Dr. Anji Reddy Memorial Lecture on Sunday, 15th March. The gathering brought together leading voices from...
16/03/2026

We had the 4th Dr. Anji Reddy Memorial Lecture on Sunday, 15th March. The gathering brought together leading voices from science and medicine for an afternoon that felt thoughtful, engaging and genuinely energizing.

Our keynote speaker, Prof. Guido Kroemer (recipient of the Léopold Griffuel Prize), shared fascinating insights on ACBP/DBI and its role in cellular stress, renewal and aging. His talk opened up fresh ways of thinking about where future therapies could evolve , the kind of ideas that stay with you long after the session ends.

We also heard from Dr. Guru N. Reddy, Founder and Chairman of Continental Hospitals, who spoke about Dr. Anji Reddy’s clarity of purpose and his lifelong effort to advance research and make quality medicines accessible to all. His reflections added a personal depth to the afternoon and reminded everyone why this legacy continues to matter.

The fourth Dr. Anji Reddy Memorial Lecture is just around the corner on Sunday, 15 March at 10 am. Block your calendars ...
13/03/2026

The fourth Dr. Anji Reddy Memorial Lecture is just around the corner on Sunday, 15 March at 10 am. Block your calendars now!

This year, we welcome Professor Guido Kroemer, recipient of the Léopold Griffuel Prize, and Dr. Guru N. Reddy, Founder and Chairman of Continental Hospitals, as our keynote speakers. These sessions promise their unique perspective on scientific discoveries, honest insights and a humane view of how knowledge becomes better care for us all.

Launched in 2023, this annual lecture series has grown into a thoughtful space at the intersection of science, society, and sustainability, the very principles that guided our founder’s life and work. As we continue this journey, we invite you to join us online to celebrate the vision of Dr. K. Anji Reddy, the scientist, entrepreneur, and philanthropist who continues to inspire us.

YouTube Live link: https://www.youtube.com/live/UmyuGAA-e0w

08/03/2026

This , we explored how women see themselves at work and how their colleagues see them.

When someone said, “I’m trying,” a colleague saw them as “someone who sets things in motion.”
When she said, “I’m still learning,” others felt, “She helps the rest of us learn better.”
When she recognized her team, her team described her presence as “calming”

These gentle contrasts reminded us how we often know the value women bring to the spaces we share. Yet, they tend to undervalue themselves and even we don’t always say it out loud.
Say It Unconditionally is our attempt to give voice to what we already feel, and to ensure appreciation is spoken in ways women can truly hear.

Address

Dr. Reddy's Laboratories Limited (Corporate Office), Door No 8-2-337, Road No 3, Banjara Hills
Hyderabad
500034

Alerts

Be the first to know and let us send you an email when Dr. Reddy's Laboratories Ltd. posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Share